Patients with cancer and concomitant rheumatoid arthritis pose special challenges. Many therapies for rheumatoid arthritis can increase the risk of adverse events during cancer therapy because they are immunosuppressive.
Kristina Goutsouliak, MD
Advertisement
Articles by Kristina Goutsouliak, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Palbociclib Combo in HR+, HER2+ Metastatic Breast Cancer
2
Sacituzumab Govitecan Receives FDA Approval Across 2 TNBC Indications
3
NCCN Updates Bladder Cancer Guidelines for ctDNA MRD Testing
4
Zanzalintinib/Atezolizumab Misses Survival End Point in Non-MSI-H mCRC Subgroup
5